Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
about
REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasisSulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlothoLiver-specific activities of FGF19 require Klotho betaBile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expressionFGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesisPotent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acidsManaging bile acid diarrhoeaEndocrine fibroblast growth factors 15/19 and 21: from feast to famineBile acids: regulation of synthesisMolecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily membersBile acid metabolism and signalingMetabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literaturePlasticity in Interactions of Fibroblast Growth Factor 1 (FGF1) N Terminus with FGF Receptors Underlies Promiscuity of FGF1Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted stateBile Acid diarrhea: prevalence, pathogenesis, and therapyBile acid signaling in metabolic disease and drug therapyReview article: bile acid diarrhoea - pathogenesis, diagnosis and managementDiet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levelsFGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathwaysDifferences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery.LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouseEffects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transportersLowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucoseA putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes.Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity.The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.Advances in understanding of bile acid diarrhea.Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individualsThe response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid.Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test.Serum levels of fibroblast growth factor 19 are inversely associated with coronary artery disease in chinese individualsThe G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling
P2860
Q21145813-799F5937-4288-49C8-ACA5-A931846377E8Q24306135-126A95A7-B095-4243-B359-0B4B4E4923AAQ24319088-913585AB-E261-45A7-B7FE-89DDCF6ACD69Q24336351-A5676CDF-C48E-4B39-BC58-114F4EEFD32EQ24617480-FF9EA672-A31C-4FF2-A9A4-B08CDD558F63Q24628720-FDB863E2-4F86-4761-8A33-9138FACFB284Q24629001-C43335D3-AC36-4E92-A60C-E625C18360EBQ24629260-D3B36191-6D65-4763-BB4E-C999481EC7FCQ24658139-2E865362-8853-418E-A3DD-E45D24F8B71BQ24683254-7CD2E95B-2A74-45E1-88AF-5F3087AB4D50Q27002873-BD6A6329-266F-4D10-8835-151FC1C0CAD5Q27010589-20750C3A-723D-4E12-B1E7-EB1F5857CF45Q27675418-521ACE15-40B6-4B94-90C4-68480D077C7DQ28070054-ACA33A28-6406-4747-A2BD-34FE22079324Q28086845-E8B235F0-CB08-44D8-BDF7-EF30272B93B1Q28244875-D00519FA-46D4-4034-9E53-7D2550D24B42Q28273649-F90EB804-2C4E-4049-A6E1-7ED659AB0496Q28593904-D00E9AEB-9E04-43FE-B9BB-53B5AD253850Q28741802-57064820-92C5-4FB0-A495-86E3F24E860BQ30277979-E1ED54DE-671F-46D7-9B94-473CD426FF85Q30491802-6B17ADBA-6AB9-4375-AE12-081D9292CD89Q33632959-96D1997C-5F4F-48EE-990F-55A163E331B8Q33751398-50C7956A-01CC-4728-9414-2745009E0C50Q33827979-4CA766A7-5B4D-4978-8822-1ADA1A42BA41Q33920932-F0CCA10E-C364-4A8F-94DC-00BE0C5EF897Q33993142-A1D0BEA8-4EEF-47CA-BF51-5420BBE61F5FQ34024552-692F7ADF-7AD8-4A8B-8809-5C917A0DBBB9Q34094150-EFAE7266-7B2F-46D5-85F3-D944D9F2D61EQ34142506-DE316AEA-A3DB-4009-B009-45C571B291B9Q34146701-46CE2749-FFC1-4C06-8E4D-35956F3362D8Q34219880-B14BFCA5-77F0-4774-B3EB-E38303BA61A9Q34366988-996FF4A3-065B-42B4-9A88-F1CDB330676DQ34412381-8413708A-C172-458B-A02A-7B0CD3808636Q34418685-0B1AD50F-00F2-44D6-A3BD-1386E8E20D81Q34444158-55FFA797-0126-473E-906A-3E5721F3AC90Q34451281-511A9EE7-4733-4C4B-904D-73B00A3F5BB0Q34493836-78A1112D-26FB-458E-B579-5F0C6CFD9760Q34793530-2A8BE157-7F28-4F86-AF98-09A76BA779EFQ34938380-64C8370F-FBCE-4414-AA4F-AB71800CB411Q35001264-F5CF5E6B-4E5E-49E0-A7BE-BA83255B91F3
P2860
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Circulating intestinal fibrobl ...... ic bile acid synthesis in man.
@en
Circulating intestinal fibrobl ...... ic bile acid synthesis in man.
@nl
type
label
Circulating intestinal fibrobl ...... ic bile acid synthesis in man.
@en
Circulating intestinal fibrobl ...... ic bile acid synthesis in man.
@nl
prefLabel
Circulating intestinal fibrobl ...... ic bile acid synthesis in man.
@en
Circulating intestinal fibrobl ...... ic bile acid synthesis in man.
@nl
P2093
P2860
P1476
Circulating intestinal fibrobl ...... ic bile acid synthesis in man.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2006.01731.X
P407
P577
2006-12-01T00:00:00Z